Takahashi, Kanji
Cheung, Chui Ming Gemmy
Iida, Tomohiro
Lai, Timothy Y. Y.
Ohji, Masahito
Yanagi, Yasuo
Kawano, Mika
Ohsawa, Shino
Suzuki, Tomoyuki
Kotecha, Aachal
Lin, Hugh
Patel, Vaibhavi
Swaminathan, Balakumar
Lee, Won Ki
,
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Chugai Pharmaceutical Co., Ltd
Article History
Received: 11 January 2023
Revised: 30 March 2023
Accepted: 11 April 2023
First Online: 9 June 2023
Declarations
:
: The TENAYA and LUCERNE trials were conducted in accordance with the International Council for Harmonisation E6 Guideline for Good Clinical Practice; tenets of the Declaration of Helsinki; applicable US Food and Drug Administration regulations and the European Union Clinical Trials Directive (2001/20/EC); and relevant local, state, and federal laws. Study protocols were approved by institutional review boards and ethics committees as applicable.
: Written informed consent was obtained from all patients in the TENAYA and LUCERNE trials.
: Not applicable.
: KT has received rewards from Bayer, Chugai Pharmaceutical Co., Ltd, Kyowa Kirin, Novartis Pharma, Santen, and Senju. CMGC is a consultant for Allergan, Bayer, Boehringer Ingelheim, Novartis, Roche, Samsung, and Topcon. TI is a consultant for Bayer, Boehringer Ingelheim, Chugai Pharmaceutical Co., Ltd/Roche, Novartis, and Senju. TYYL receives research support from Bayer, Novartis, and Roche and is a consultant for Alcon, Allergan, Bayer, Boehringer Ingelheim, Novartis, Oculis, and Roche. MO receives speaking fees from Chugai Pharmaceutical Co., Ltd. YY receives financial support from Alcon Japan, Sanbio, and Santen Pharmaceuticals and speaking fees from Chugai Pharmaceutical Co., Ltd. MK, SO, and TS are employees of Chugai Pharmaceutical Co., Ltd. AK and VP are employees of Roche Products Ltd. HL is an employee of Genentech, Inc. BS is an employee of F. Hoffman-La Roche Ltd. WKL is a consultant for Bayer, Novartis, and Roche.